Novel cycloheximide derivatives targeting the moonlighting protein Mip exhibit specific antimicrobial activity against Legionella pneumophila

Frontiers in Bioengineering and Biotechnology

Volumn 3, Issue MAR, 2015, Pages

  Rasch, Janine ^a   Theuerkorn, Martin ^b   Ünal, Can ^a,c   Heinsohn, Natascha ^a   Tran, Stefan ^a   Fischer, Gunter ^b,d   Weiwad, Matthias ^b,d   Steinert, Michael ^a,e  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^b MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^c TURKISH GERMAN UNIVERSITY   (Turkey)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Adamantane; Cycloheximide; Inhibitor; Moonlighting; PPIase

Indexed keywords

CHELATION; MACROPHAGES;

ADAMANTANES; CYCLOHEXIMIDES; INHIBITOR; MOONLIGHTING; PPIASE;

PROTEINS;

EID: 84940117734     PISSN: None     EISSN: 22964185     Source Type: Journal    
DOI: 10.3389/fbioe.2015.00041     Document Type: Article

References (36)

1. Babine, R. E., Bleckman, T. M., Kissinger, C. R., Showalter, R., Pelletier, L. A., Lewis, C., et al. (1995). Design, synthesis and X-ray crystallographic studies of novel FKBP-12 ligands. Bioorg. Med. Chem. Lett. 5, 1719-1724. doi: 10.1016/0960-894X(95)00290-A.
2. Begley, D. W., Fox, D., Jenner, D., Juli, C., Pierce, P. G., Abendroth, J., et al. (2014). A structural biology approach enables the development of antimicrobials targeting bacterial immunophilins. Antimicrob. Agents Chemother. 58, 1458-1467. doi:10.1128/AAC.01875-13.
3. Boytim, M. L., Lilly, P., Drouvalakis, K., Lyu, S. C., Jung, R., Krensky, A. M., et al. (2000). A human class II MHC-derived peptide antagonizes phosphatidylinositol 3-kinase to block IL-2 signaling. J. Clin. Invest. 105, 1447-1453. doi:10.1172/JCI8139.
4. Ceymann, A., Horstmann, M., Ehses, P., Schweimer, K., Paschke, A.-K., Steinert, M., et al. (2008). Solution structure of the Legionella pneumophila Mip-rapamycin complex. BMC Struct. Biol. 8:17. doi:10.1186/1472-6807-8-17.
5. Christner, C., Wyrwa, R., Marsch, S., Küllertz, G., Thiericke, R., Grabley, S., et al. (1999). Synthesis and cytotoxic evaluation of cycloheximide derivatives as potential inhibitors of FKBP12 with neuroregenerative properties. J. Med. Chem. 42, 3615-3622. doi:10.1021/jm991038t.
6. Cianciotto, N. P., Bangsborg, J. M., Eisenstein, B. I., and Engleberg, N. C. (1990). Identification of mip-like genes in the genus Legionella. Infect. Immun. 58, 2912-2918.
7. Cianciotto, N. P., Eisenstein, B. I., Mody, C. H., Toews, G. B., and Engleberg, N. C. (1989). A Legionella pneumophila gene encoding a species-specific surface protein potentiates initiation of intracellular infection. Infect. Immun. 57, 1255-1262.
8. Cianciotto, N. P., and Fields, B. S. (1992). Legionella pneumophila mip gene potentiates intracellular infection of protozoa and human macrophages. Proc. Natl. Acad. Sci. U.S.A. 89, 5188-5191. doi:10.1073/pnas.89.11.5188.
9. Cianciotto, N. P., O'Connell, W., Dasch, G. A., and Mallavia, L. P. (1995). Detection of mip-like sequences and Mip-related proteins within the family Rickettsiaceae. Curr. Microbiol. 30, 149-153. doi:10.1007/BF00296200.
10. Edlich, F., Weiwad, M., Wildemann, D., Jarczowski, F., Kilka, S., Moutty, M. C., et al. (2006). The specific FKBP38 inhibitor N-(N', N'-dimethylcarboxamidomethyl) cycloheximide has potent neuroprotective and neurotrophic properties in brain ischemia. J. Biol. Chem. 281, 14961-14970. doi:10.1074/jbc. M600452200.
11. Engleberg, N. C., Carter, C., Weber, D. R., Cianciotto, N. P., and Eisenstein, B. I. (1989). DNA sequence of mip, a Legionella pneumophila gene associated with macrophage infectivity. Infect. Immun. 57, 1263-1270.
12. Fields, B. S., Benson, R. F., and Besser, R. E. (2002). Legionella and Legionnaires' disease: 25 years of investigation. Clin. Microbiol. Rev. 15, 506-526. doi:10.1128/CMR.15.3.506-526.2002.
13. Fischer, G., Bang, H., Ludwig, B., Mann, K., and Hacker, J. (1992). Mip protein of Legionella pneumophila exhibits peptidyl-prolyl-cis/trans isomerase (PPlase) activity. Mol. Microbiol. 6, 1375-1383. doi:10.1111/j.1365-2958.1992.tb00858.x.
14. Fischer, G., Wittmann-Liebold, B., Lang, K., Kiefhaber, T., and Schmid, F. X. (1989). Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 337, 476-478. doi:10.1038/337476a0.
15. Gaali, S., Gopalakrishnan, R., Wang, Y., Kozany, C., and Hausch, F. (2011). The chemical biology of immunophilin ligands. Curr. Med. Chem. 18, 5355-5379. doi:10.2174/092986711798194342.
16. Ge, X., Lyu, Z.-X., Liu, Y., Wang, R., Zhao, X. S., Fu, X., et al. (2014). Identification of FkpA as a key quality control factor for the biogenesis of outer membrane proteins under heat shock conditions. J. Bacteriol. 196, 672-680. doi:10.1128/JB.01069-13.
17. Harikishore, A., Niang, M., Rajan, S., Preiser, P. R., and Yoon, H. S. (2013). Small molecule Plasmodium FKBP35 inhibitor as a potential antimalaria agent. Sci. Rep. 3, 2501. doi:10.1038/srep02501.
18. Helbig, J. H., Lück, P. C., Steinert, M., Jacobs, E., and Witt, M. (2001). Immunolocalization of the Mip protein of intracellularly and extracellularly grown Legionella pneumophila. Lett. Appl. Microbiol. 32, 83-88. doi:10.1046/j.1472-765x.2001.00861.x.
19. Henderson, B., and Martin, A. C. R. (2014). Protein moonlighting: a new factor in biology and medicine. Biochem. Soc. Trans. 42, 1671-1678. doi:10.1042/BST20140273.
20. Hoffmann, A., Bukau, B., and Kramer, G. (2010). Structure and function of the molecular chaperone trigger factor. Biochim. Biophys. Acta 1803, 650-661. doi:10.1016/j.bbamcr.2010.01.017.
21. Juli, C., Sippel, M., Jäger, J., Thiele, A., Weiwad, M., Schweimer, K., et al. (2011). Pipecolic acid derivatives as small-molecule inhibitors of the Legionella MIP protein. J. Med. Chem. 54, 277-283. doi:10.1021/jm101156y.
22. Köhler, R., Fanghänel, J., König, B., Lüneberg, E., Frosch, M., Rahfeld, J.-U., et al. (2003). Biochemical and functional analyses of the Mip protein: influence of the N-terminal half and of peptidylprolyl isomerase activity on the virulence of Legionella pneumophila. Infect. Immun. 71, 4389-4397. doi:10.1128/IAI.71.8.4389-4397.2003.
23. Lang, K., Schmid, F. X., and Fischer, G. (1987). Catalysis of protein folding by prolyl isomerase. Nature 329, 268-270. doi:10.1038/329268a0.
24. Leuzzi, R., Serino, L., Scarselli, M., Savino, S., Fontana, M. R., Monaci, E., et al. (2005). Ng-MIP, a surface-exposed lipoprotein of Neisseria gonorrhoeae, has a peptidyl-prolyl cis/trans isomerase (PPIase) activity and is involved in persistence in macrophages. Mol. Microbiol. 58, 669-681. doi:10.1111/j.1365-2958.2005.04859.x.
25. Liu, J., Albers, M. W., Wandless, T. J., Luan, S., Alberg, D. G., Belshaw, P. J., et al. (1992). Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry 31, 3896-3901. doi:10.1021/bi00131a002.
26. Lundemose, A. G., Kay, J. E., and Pearce, J. H. (1993). Chlamydia trachomatis Mip-like protein has peptidyl-prolyl cis/trans isomerase activity that is inhibited by FK506 and rapamycin and is implicated in initiation of chlamydial infection. Mol. Microbiol. 7, 777-783. doi:10.1111/j.1365-2958.1993.tb01168.x.
27. Mo, Y. Y., Cianciotto, N. P., and Mallavia, L. P. (1995). Molecular cloning of a Coxiella burnetii gene encoding a macrophage infectivity potentiator (Mip) analogue. Microbiology 141(Pt 11), 2861-2871. doi:10.1099/13500872-141-11-2861.
28. Moro, A., Ruiz-Cabello, F., Fernández-Cano, A., Stock, R. P., and González, A. (1995). Secretion by Trypanosoma cruzi of a peptidyl-prolyl cis-trans isomerase involved in cell infection. EMBO J. 14, 2483-2490.
29. Norville, I. H., O'Shea, K., Sarkar-Tyson, M., Zheng, S., Titball, R. W., Varani, G., et al. (2011). The structure of a Burkholderia pseudomallei immunophilin-inhibitor complex reveals new approaches to antimicrobial development. Biochem. J. 437, 413-422. doi:10.1042/BJ20110345.
30. Rasch, J., Unal, C. M., and Steinert, M. (2014). Peptidylprolyl cis-trans isomerases of Legionella pneumophila: virulence, moonlighting and novel therapeutic targets. Biochem. Soc. Trans. 42, 1728-1733. doi:10.1042/BST20140202.
31. Riboldi-Tunnicliffe, A., König, B., Jessen, S., Weiss, M. S., Rahfeld, J., Hacker, J., et al. (2001). Crystal structure of Mip, a prolylisomerase from Legionella pneumophila. Nat. Struct. Biol. 8, 779-783. doi:10.1038/nsb0901-779.
32. Rockey, D. D., Chesebro, B. B., Heinzen, R. A., and Hackstadt, T. (1996). A 28 kDa major immunogen of Chlamydia psittaci shares identity with Mip proteins of Legionella spp. and Chlamydia trachomatis-cloning and characterization of the C. psittaci mip-like gene. Microbiology 142(Pt 4), 945-953. doi:10.1099/00221287-142-4-945.
33. Ünal, C., Schwedhelm, K. F., Thiele, A., Weiwad, M., Schweimer, K., Frese, F., et al. (2011). Collagen IV-derived peptide binds hydrophobic cavity of Legionella pneumophila Mip and interferes with bacterial epithelial transmigration. Cell. Microbiol. 13, 1558-1572. doi:10.1111/j.1462-5822.2011.01641.x.
34. Ünal, C. M., and Steinert, M. (2014). Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets. Microbiol. Mol. Biol. Rev. 78, 544-571. doi:10.1128/MMBR.00015-14.
35. Wagner, C., Khan, A. S., Kamphausen, T., Schmausser, B., Ünal, C., Lorenz, U., et al. (2007). Collagen binding protein Mip enables Legionella pneumophila to transmigrate through a barrier of NCI-H292 lung epithelial cells and extracellular matrix. Cell. Microbiol. 9, 450-462. doi:10.1111/j.1462-5822.2006.00802.x.
36. Wintermeyer, E., Ludwig, B., Steinert, M., Schmidt, B., Fischer, G., and Hacker, J. (1995). Influence of site specifically altered Mip proteins on intracellular survival of Legionella pneumophila in eukaryotic cells. Infect. Immun. 63, 4576-4583.